Harmony Biosciences appointed Peter Anastasiou as Senior Executive Vice President and Chief Operating Officer effective April 2, 2026, prompting his resignation from the Board; Troy Ignelzi was appointed to fill the resulting Class III director vacancy, and Antonio Gracias will not stand for re-election at the 2026 Annual Meeting.